Towards Healthcare
Rapid Microbial Testing Market to Promote USD 13.63 Bn by 2034

Rapid Microbial Testing Market Revolutionizing Pharma and Food Safety

Projections indicate that, the global rapid microbial testing market will increase from USD 5.25 billion in 2024 to USD 13.63 billion by 2034, experiencing a CAGR of 10.04% over the next 10 years. The market is growing due to increasing infectious disease cases, stringent food and pharmaceutical safety regulations, and advancements in rapid diagnostic technologies. North America dominates the market owing to its strong healthcare infrastructure, high R&D investments, and early adoption of innovative testing methods.

Content

  • Last Updated: 17 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The rapid microbial testing market stands at USD 5.78 billion in 2025 and is expected to reach USD 13.63 billion by 2034, growing at a CAGR of 10.04% from 2024 to 2034.

North America is currently leading the rapid microbial testing market due to strong regulatory frameworks and substantial investments in healthcare infrastructure.

Merck KGaA, Thermo Fisher Scientific, Charles River Laboratories, Sartorius AG, Lonza Group, Microbial Detection Technologies, Pall Corporation 

Techniques include PCR-based methods, MALDI-TOF MS, microfluidics lab-on-a-chip, immunoassays, and ATP bioluminescence.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions